Attached files

file filename
8-K - 8-K - IMAX CORPd677915d8k.htm

Exhibit 99.1

IMAX CORPORATION

 

LOGO

IMAX CORPORATION

2525 Speakman Drive

Mississauga, Ontario, Canada L5K 1B1

Tel: (905) 403-6500 Fax: (905) 403-6450

www.imax.com

IMAX CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2013 FINANCIAL RESULTS

HIGHLIGHTS

 

    Robust performance in Q4 leads to adjusted EPS of $0.44, 91% growth over same period last year, drives full year adjusted EPS to $0.81

 

    Highest global box office quarter ever for IMAX of $244 million, brings full year 2013 box office to $727 million

 

    IMAX has record year for signings with 119 signings in Q4 and 277 in the full year, double that of 2012

 

    IMAX expands backlog to historical high of 384 new commercial theatres, a 45% increase year-over-year

NEW YORK, NY – Feb. 20, 2014 – IMAX Corporation (NYSE:IMAX; TSX:IMX) today reported robust fourth quarter 2013 financial results driven by the combination of strong installations as well as its highest grossing quarterly global box office ever. The Company reported revenues for the fourth quarter 2013 of $105.1 million, adjusted EBITDA as calculated in accordance with the Company’s credit facility of $52.2 million, adjusted net income of $30.8 million, or $0.44 per diluted share, and reported net income of $27.8 million, or $0.40 per diluted share. The Company also reported a fourth quarter per screen average of $366,300.

Full year 2013 revenues were $287.9 million, adjusted EBITDA as calculated in accordance with the Company’s credit facility was $113.2 million, adjusted net income was $55.7 million, or $0.81 per diluted share, and reported net income was $44.1 million, or $0.64 per diluted share. For reconciliations of adjusted net income to reported net income and for the definition of adjusted EBITDA and free cash flow, please see the tables at the end of this press release. The Company also reported a 2013 per screen average of $1.15 million. With the exception of 2010, when the Company’s per screen average was much higher driven by Avatar, the Company’s per screen averages over the past 5 years have been in a range of approximately $1.1 to $1.2 million.

“IMAX fired on all cylinders in the fourth quarter, with an exceptional number of installations and signings, as well as the highest grossing box office in the Company’s history,” said IMAX CEO, Richard L. Gelfond. “Breakout performances by films such as Gravity, Hobbit, and Stalingrad internationally, exemplify the power and differentiation of the IMAX format.” Gelfond continued, “The strong fourth quarter drove over 90% growth in our EBITDA compared to the same period last year, resulting in margin expansion and strong operating leverage for the full year. Overall, 2013 was a very exciting and productive year at IMAX as we effectively streamlined costs, expanded the network, signed a record number of deals and continued to execute on the film front.”

Network Growth Update

In the fourth quarter of 2013, the Company signed contracts for 119 theatre systems and installed 58 theatre systems, of which 4 were upgrades of existing theatre locations, bringing the full year total installations to 112 new theatre systems across 23 countries.

“With our footprint now spanning 57 countries, IMAX is more global than ever before,” added Gelfond. “Moving forward, we are focused on managing all aspects of our business to ensure that we take full advantage of attractive movie-going trends unique to each local market and that we secure IMAX’s position as the world’s premium cinematic experience. Our record level of signings in 2013 will drive ongoing network growth, and we are optimistic about what the future holds.”

 

1


The total IMAX® theatre network consisted of 837 systems as of December 31, 2013, of which 701 were in commercial multiplexes. IMAX signed contracts for 277 theatres in 2013, across 31 countries, resulting in 407 theatre systems in backlog as of December 31, 2013, compared to 276 theatre systems in backlog as of December 31, 2012. For a breakdown of theatre system signings, installations, network and backlog by type, please see the end of this press release.

Fourth-Quarter Segment Results

 

    Revenue from sales and sales-type leases was $32.6 million in the fourth quarter of 2013, compared to $20.2 million in the fourth quarter of 2012, primarily reflecting the installation of 24 full, new theatre systems under sales and sales-type lease arrangements in the most recent fourth quarter, compared to the 14 in the fourth quarter of 2012. In addition there were 4 digital system upgrades in existing locations in the fourth quarter of 2013, compared to 3 upgrades in the fourth quarter of 2012.

 

    Revenue from joint revenue-sharing arrangements was $24.5 million in the quarter, compared to $17.0 million in the prior-year period. During the quarter, the Company installed 30 new theatres under joint revenue-sharing arrangements, compared to 29 in the year ago period. The Company had 382 theatres operating under joint revenue-sharing arrangements as of December 31, 2013, as compared to 316 theatres one year prior.

 

    Production and IMAX DMR® (Digital Re-Mastering) revenues were $28.6 million in the fourth quarter of 2013, compared to $19.2 million in the fourth quarter of 2012. Gross box office from DMR titles was $244.5 million in the fourth quarter of 2013, compared to $152.0 million in the prior-year period. The average global DMR box office per screen in the fourth quarter of 2013 was $366,300 compared to $264,400 in the prior-year period.

Conference Call

The Company will host a conference call today at 8:30 AM ET to discuss its fourth quarter and full year 2013 financial results. To access the call via telephone, interested parties in the US and Canada should dial (800) 820-0231 approximately 5 to 10 minutes before the call begins. International callers should dial (416) 640-5926. The conference ID for the call is 9729185. A replay of the call will be available via webcast on the ‘Investor Relations’ section of www.imax.com or via telephone by dialing (888) 203-1112 (US and Canada), or (647) 436-0148 (international). The Conference ID for the telephone replay is 9729185.

About IMAX Corporation

IMAX, an innovator in entertainment technology, combines proprietary software, architecture and equipment to create experiences that take you beyond the edge of your seat to a world you’ve never imagined. Top filmmakers and studios are utilizing IMAX theatres to connect with audiences in extraordinary ways, and, as such, IMAX’s network is among the most important and successful theatrical distribution platforms for major event films around the globe.

IMAX is headquartered in New York, Toronto and Los Angeles, with offices in London, Tokyo, Shanghai and Beijing. As of Dec. 31, 2013, there were 837 IMAX theatres (701 commercial multiplexes, 19 commercial destinations and 117 institutions) in 57 countries.

IMAX®, IMAX® 3D, IMAX DMR®, Experience It In IMAX®, An IMAX 3D Experience®, The IMAX Experience®, IMAX Is Believing® and IMAX nXos® are trademarks of IMAX Corporation. More information about the Company can be found at www.imax.com. You may also connect with IMAX on Facebook (www.facebook.com/imax), Twitter (www.twitter.com/imax) and YouTube (www.youtube.com/imaxmovies).

###

This press release contains forward looking statements that are based on IMAX management’s assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. Important factors that could affect these statements include, but are not limited to, references to future capital expenditures (including the amount and nature thereof), business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, plans and references to the future success of IMAX Corporation together with its wholly-owned subsidiaries (the “Company”) and expectations regarding the Company’s future operating, financial and technological results. These forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and

 

2


its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform with the expectations and predictions of the Company is subject to a number of risks and uncertainties, including, but not limited to, general economic, market or business conditions; the opportunities (or lack thereof) that may be presented to and pursued by the Company; the performance of IMAX DMR films; competitive actions by other companies; conditions in the in-home and out-of-home entertainment industries; the signing of theater system agreements; changes in laws or regulations; conditions, changes and developments in the commercial exhibition industry; risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United States and Canada; risks related to the Company’s growth and operations in China; the failure to respond to change and advancements in digital technology; the Company’s largest customer accounting for a significant portion of the Company’s revenue and backlog; risks related to new business initiatives; the potential impact of increased competition in the markets within which the Company operates; risks related to the Company’s inability to protect the Company’s intellectual property; risks related to the Company’s implementation of a new enterprise resource planning system; the failure to convert theater system backlog into revenue; risks related to the Company’s dependence on a sole supplier for its analog film; and other factors, many of which are beyond the control of the Company. These factors, other risks and uncertainties and financial details are discussed in IMAX’s most recent Annual Report on Form 10-K.

For additional information please contact:

 

Investors:

IMAX Corporation, New York

Teri Loxam

212-821-0100

tloxam@imax.com

 

Business Media:

Sloane & Company, New York

Whit Clay

212-446-1864

wclay@sloanepr.com

    

Media:

IMAX Corporation, New York

Ann Sommerlath

212-821-0155

asommerlath@imax.com

 

Entertainment Media:

Principal Communications Group, Los Angeles

Melissa Zuckerman/Paul Pflug

323-658-1555

melissa@pcommgroup.com

paul@pcommgroup.com

 

3


Additional Information

Signings and Installations

 

Dec. 31, 2013

     Three Months
Ended Dec. 31,
    Twelve Months
Ended Dec. 31,
 
     2013     2012     2013     2012  

Theatre Signings:

        

Full new sales and sales -type lease arrangements

     18        11        56        43   

New joint revenue sharing arrangements

     98        17        190        78   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total new theatres

     116        28        246        121   

Upgrades of IMAX theatre systems

     3        10        31 (1)      21 (2) 
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Theatre Signings

     119        38        277        142   
  

 

 

   

 

 

   

 

 

   

 

 

 
     Three Months
Ended Dec. 31,
    Twelve Months
Ended Dec. 31,
 
     2013     2012     2013     2012  

Theatre Installations:

        

Full new sales and sales -type lease arrangements

     24        14        47 (3)      47   

New joint revenue sharing arrangements

     30        29        65        60   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total new theatres

     54        43        112 (3)      107   

Upgrades of IMAX theatre systems

     4        3        21 (1)      18   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Theatre Installations

     58        46        133        125   
  

 

 

   

 

 

   

 

 

   

 

 

 
     As of Dec. 31,              
     2013     2012              

Theatre Backlog:

        

New sales and sales -type lease arrangements

     125        128       

New joint revenue sharing arrangements

     259        137       
  

 

 

   

 

 

     

Total new theatres

     384        265       

Upgrades of IMAX theatre systems

     23        11       
  

 

 

   

 

 

     

Total Theatres in Backlog

     407 (4)      276 (5)     
  

 

 

   

 

 

     
     As of Dec. 31,              
     2013     2012              

Theatre Network:

        

Commercial Multiplex Theatres:

        

Sales and sales -type lease arrangements

     319        282       

Joint revenue sharing arrangements

     382        316       
  

 

 

   

 

 

     

Total Commercial Multiplex Theatres

     701        598       

Commercial Destination Theatres

     19        19       

Institutional Theatres

     117        114       
  

 

 

   

 

 

     

Total IMAX Theatre Network

     837        731       
  

 

 

   

 

 

     

 

(1) Includes upgrades to xenon-based digital systems under short-term operating lease arrangements (10 signings, 10 installations).
(2) Includes 3 IMAX theaters acquired from another existing customer that has been operating under a joint revenue sharing arrangement. These theaters were purchased from the Company under a sales arrangement.
(3) Includes the following items: (i) one new xenon-based digital system under a short-term operating lease arrangement; (ii) one theater system which has increased the Company’s institutional theater network; and (iii) one IMAX Private Theater (the first of its kind in the IMAX theater network).
(4) Includes 23 upgrades to a digital theater system, in an existing IMAX theater location (3 xenon and 20 laser, of which 4 are under joint revenue sharing arrangements).
(5) Includes 11 upgrades to a digital theater system, in an existing IMAX theater location (6 xenon and 5 laser).

 

4


Additional Information (continued)

 

2013 DMR Films:

In 2013, 38 films were converted through the IMAX DMR process and released to theaters in the IMAX network by film studios as compared to 35 films in 2012. These films were:

 

    The Grandmaster: The IMAX Experience (Jet Tone Films and Sil-Metropole Organization, January 2013, China only);

 

    Hansel & Gretel: Witch Hunters: An IMAX 3D Experience (Paramount Pictures, January 2013);

 

    Top Gun: An IMAX 3D Experience (Paramount Pictures, February 2013);

 

    Journey to the West: Conquering the Demons: An IMAX 3D Experience (Bingo Movie Development Ltd, February 2013, China only);

 

    A Good Day to Die Hard: The IMAX Experience (Twentieth Century Fox, February 2013);

 

    Jack the Giant Slayer: An IMAX 3D Experience (Warner Bros. Pictures, March 2013);

 

    Oz: The Great and Powerful: An IMAX 3D Experience (Walt Disney Pictures, March 2013);

 

    G.I. Joe: Retaliation: An IMAX 3D Experience (Paramount Pictures, March 2013);

 

    Dragon Ball Z: Battle of the Gods: An IMAX 3D Experience (Toei Animation Company, March 2013, Japan only);

 

    Jurassic Park: An IMAX 3D Experience (Universal Pictures, April 2013);

 

    Oblivion: The IMAX Experience (Universal Pictures, April 2013);

 

    Iron Man 3: An IMAX 3D Experience (Walt Disney Pictures, May 2013);

 

    Star Trek: Into Darkness: An IMAX 3D Experience (Paramount Pictures, May 2013);

 

    Fast & Furious 6: The IMAX Experience (Universal Pictures, May 2013, select international markets);

 

    After Earth: The IMAX Experience (Columbia Pictures, May 2013);

 

    Man of Steel: The IMAX Experience (Warner Bros. Pictures, June 2013);

 

    World War Z: An IMAX 3D Experience (Paramount Pictures, June 2013, select international markets);

 

    Despicable Me 2: An IMAX 3D Experience (Universal Pictures, July 2013, select international markets);

 

    White House Down: The IMAX Experience (Sony Pictures, July 2013, select international markets);

 

    Man of Tai Chi: The IMAX Experience (China Film Group, Wanda Group, Village Roadshow, July 2013, China only);

 

    Lone Ranger: The IMAX Experience (Walt Disney Pictures, July 2013, select international markets);

 

    Pacific Rim: An IMAX 3D Experience (Warner Bros. Pictures, July 2013);

 

    Elysium: The IMAX Experience (Sony Pictures, August 2013);

 

    The Mortal Instruments: City of Bones: The IMAX Experience (Sony Pictures, August 2013);

 

    Riddick Sequel: The IMAX Experience (Universal Pictures, September 2013);

 

    The Wizard of Oz: An IMAX 3D Experience (Picturehouse, September 2013);

 

    Young Detective Dee: Rise of the Sea Dragon: An IMAX 3D Experience (Huayi Bros., September 2013, China only);

 

    Metallica Through the Never: An IMAX 3D Experience (Warner Bros. Pictures, September 2013);

 

    Gravity: An IMAX 3D Experience (Warner Bros. Pictures, October 2013);

 

    Stalingrad: An IMAX 3D Experience (AR Films, October 2013, Russia and the CIS only);

 

    Captain Phillips: The IMAX Experience (Sony Pictures, October 2013);

 

    The Young and Prodigious T.S. Spivet: An IMAX 3D Experience (Epithète Films., October 2013, France only);

 

    Thor: The Dark World: An IMAX 3D Experience (Walt Disney Pictures, October 2013, select international markets);

 

    Ender’s Game: The IMAX Experience (Lionsgate, November 2013);

 

    The Hunger Games: Catching Fire: The IMAX Experience (Lionsgate, November 2013);

 

    The Hobbit: The Desolation of Smaug: An IMAX 3D Experience (Warner Bros. Pictures, December 2013);

 

    Dhoom 3: The IMAX Experience (Yash Raj Films, December 2013, India only); and

 

    Police Story: An IMAX 3D Experience (China Vision, December 2013, China only).

 

5


IMAX CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

In accordance with United States Generally Accepted Accounting Principles

(In thousands of U.S. dollars, except per share amounts)

 

     Three Months
Ended December 31,
    Year Ended
December 31,
 
     2013     2012*     2013     2012*  

Revenues

        

Equipment and product sales

   $ 38,014     $ 22,405     $ 78,663     $ 78,161  

Services

     42,463       33,936       139,464       135,071  

Rentals

     22,511       18,356       61,293       61,268  

Finance income

     2,063       1,986       8,142       7,523  

Other

     —         732       375       732  
  

 

 

   

 

 

   

 

 

   

 

 

 
     105,051       77,415       287,937       282,755  
  

 

 

   

 

 

   

 

 

   

 

 

 

Costs and expenses applicable to revenues

        

Equipment and product sales

     16,956       9,811       37,517       37,538  

Services

     15,483       16,741       68,844       70,570  

Rentals

     5,286       8,434       16,973       21,402  

Other

     —         —         —         —    
  

 

 

   

 

 

   

 

 

   

 

 

 
     37,725       34,986       123,334       129,510  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross margin

     67,326       42,429       164,603       153,245  

Selling, general and administrative expenses (including share-based compensation expense of $3.2 million and $11.9 million for the three months and year ended December 31, 2013, respectively (2012 - expense of $2.8 million and $13.1 million, respectively))

     23,305       22,529       82,669       81,560  

Research and development

     3,504       3,788       14,771       11,411  

Amortization of intangibles

     472       174       1,618       706  

Receivable provisions, net of recoveries

     166       (305     445       524  

Impairment of available-for-sale investment

     —         —         —         150  
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from operations

     39,879       16,243       65,100       58,894  

Interest income

     16       12       55       85  

Interest expense

     (338     686       (1,345     (689
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations before income taxes

     39,557       16,941       63,810       58,290  

Provision for income taxes

     (9,927     (3,594     (16,629     (15,079

Loss from equity-accounted investments

     (1,759     (324     (2,757     (1,362
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations

     27,871       13,023       44,424       41,849  

Net loss from discontinued operations

     (42     (140     (309     (512
  

 

 

   

 

 

   

 

 

   

 

 

 

Net Income

   $ 27,829     $ 12,883     $ 44,115     $ 41,337  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income per share - Basic:

        

Net income per share from continuing operations

   $ 0.41     $ 0.20     $ 0.66     $ 0.64  

Net loss per share from discontinued operations

     —         —         —         (0.01
  

 

 

   

 

 

   

 

 

   

 

 

 
   $ 0.41     $ 0.20     $ 0.66     $ 0.63  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income per share - Diluted:

        

Net income per share from continuing operations

   $ 0.40     $ 0.19     $ 0.64     $ 0.62  

Net loss per share from discontinued operations

     —         —         —         (0.01
  

 

 

   

 

 

   

 

 

   

 

 

 
   $ 0.40     $ 0.19     $ 0.64     $ 0.61  
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average number of shares outstanding (000’s):

        

Basic

     67,696       66,264       67,151       65,854  

Fully Diluted

     69,334       68,281       68,961       67,933  

Additional Disclosure:

        

Depreciation and amortization(1)

   $ 8,145     $ 8,084     $ 37,172     $ 32,788  

 

(1) Includes $0.1 million and $0.5 million of amortization of deferred financing costs charged to interest expense for the three months and year ended December 31, 2013 (2012 - less than $0.1 million and $0.2 million respectively).
* Includes a reclass of the Company’s owned and operated Nyack theater from continuing operations to discontinued operations.

 

6


IMAX CORPORATION

CONSOLIDATED BALANCE SHEETS

In accordance with United States Generally Accepted Accounting Principles

(In thousands of U.S. dollars)

 

     As at December 31,  
     2013     2012  

Assets

    

Cash and cash equivalents

   $ 29,546     $ 21,336  

Accounts receivable, net of allowance for doubtful accounts of $887 (December 31, 2012 — $1,564)

     73,074       42,007  

Financing receivables

     107,110       94,193  

Inventories

     9,825       15,794  

Prepaid expenses

     3,602       3,833  

Film assets

     7,076       3,737  

Property, plant and equipment

     132,847       113,610  

Other assets

     27,034       23,963  

Deferred income taxes

     24,259       36,461  

Goodwill

     39,027       39,027  

Other intangible assets

     27,745       27,911  
  

 

 

   

 

 

 

Total assets

   $ 481,145     $ 421,872  
  

 

 

   

 

 

 

Liabilities

    

Bank indebtedness

   $ —       $ 11,000  

Accounts payable

     19,396       15,144  

Accrued and other liabilities

     65,232       68,695  

Deferred revenue

     76,932       73,954  
  

 

 

   

 

 

 

Total liabilities

     161,560       168,793  
  

 

 

   

 

 

 

Commitments and contingencies

    

Shareholders’ equity

    

Capital stock common shares — no par value. Authorized — unlimited number.

    

Issued and outstanding — 67,841,233 (December 31, 2012 — 66,482,425)

     327,313       313,744  

Other equity

     36,452       28,892  

Deficit

     (43,051     (87,166

Accumulated other comprehensive loss

     (1,129     (2,391
  

 

 

   

 

 

 

Total shareholders’ equity

     319,585       253,079  
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $ 481,145     $ 421,872  
  

 

 

   

 

 

 

 

7


IMAX CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

In accordance with United States Generally Accepted Accounting Principles

(In thousands of U.S. dollars)

 

     Years Ended December 31,  
     2013     2012*  

Cash provided by (used in):

    

Operating Activities

    

Net income

   $ 44,115     $ 41,337  

Net loss from discontinued operations

     309       512  

Adjustments to reconcile net income to cash from operations:

    

Depreciation and amortization

     37,172       32,788  

Write-downs, net of recoveries

     1,336       1,607  

Change in deferred income taxes

     12,899       14,724  

Stock and other non-cash compensation

     12,685       14,220  

Unrealized foreign currency exchange loss (gain)

     1,183       (329

Gain on curtailment of postretirement benefits

     (2,185     —    

Loss from equity-accounted investments

     2,757       1,362  

Investment in film assets

     (20,935     (16,817

Changes in other non-cash operating assets and liabilities

     (33,755     (15,262

Net cash used in operating activities from discontinued operations

     (548     (512
  

 

 

   

 

 

 

Net cash provided by operating activities

     55,033       73,630  
  

 

 

   

 

 

 

Investing Activities

    

Purchase of property, plant and equipment

     (13,016     (6,055

Investment in joint revenue sharing equipment

     (22,775     (23,257

Investment in new business ventures

     (4,000     (381

Acquisition of other intangible assets

     (2,486     (5,826
  

 

 

   

 

 

 

Net cash used in investing activities

     (42,277     (35,519
  

 

 

   

 

 

 

Financing Activities

    

Increase in bank indebtedness

     12,000       9,917  

Repayment of bank indebtedness

     (23,000     (54,000

Common shares issued - stock options exercised

     8,970       8,920  

Proceeds from disgorgement of stock sale profits

     —         314  

Credit Facility amendment fees paid

     (2,151     —    

Share issuance expenses

     (202     —    
  

 

 

   

 

 

 

Net cash used in financing activities

     (4,383     (34,849
  

 

 

   

 

 

 

Effects of exchange rate changes on cash

     (163     (64
  

 

 

   

 

 

 

Increase in cash and cash equivalents during year

     8,210       3,198  

Cash and cash equivalents, beginning of year

     21,336       18,138  
  

 

 

   

 

 

 

Cash and cash equivalents, end of year

   $ 29,546     $ 21,336  
  

 

 

   

 

 

 

 

* Includes a reclass of the Company’s owned and operated Nyack theater from continuing operations to discontinued operations.

 

8


IMAX CORPORATION

SELECTED FINANCIAL DATA

In accordance with United States Generally Accepted Accounting Principles

(In thousands of U.S. dollars)

The Company has seven reportable segments identified by category of product sold or service provided: IMAX systems; theater system maintenance; joint revenue sharing arrangements; film production and IMAX DMR; film distribution; film post-production; and other. The IMAX systems segment is comprised of the design, manufacture, sale or lease IMAX theater projection system equipment. The theater system maintenance segment consists of the maintenance of IMAX theater projection system equipment in the IMAX theater network. The joint revenue sharing arrangements segment is comprised of the installation IMAX theater projection system equipment to an exhibitor in exchange for a certain percentage of box-office receipts, concession revenue and in some cases a small upfront or initial payment. The film production and IMAX DMR segment is comprised of the production of films and performance of film re-mastering services. The film distribution segment includes the distribution of films for which the Company has distribution rights. The film post-production segment includes the provision of film post-production and film print services. The other segment includes certain IMAX theaters that the Company owns and operates, camera rentals and other miscellaneous items.

 

     Three Months      Year Ended  
     Ended December 31,      December 31,  
     2013     2012(*)      2013      2012(*)  

Revenue

          

IMAX Theater Systems

          

IMAX Systems

          

Sales and sales-type leases

   $ 32,623     $ 20,237      $ 65,944      $ 69,988  

Ongoing rent, fees, and finance income

     4,134       4,105        14,245        13,417  

Other

     3,838       3,802        11,182        13,019  
  

 

 

   

 

 

    

 

 

    

 

 

 
     40,595       28,144        91,371        96,424  
  

 

 

   

 

 

    

 

 

    

 

 

 

Theater system maintenance

     8,134       7,751        31,978        28,629  
  

 

 

   

 

 

    

 

 

    

 

 

 

Joint revenue sharing arrangements

     24,458       17,049        64,130        57,526  
  

 

 

   

 

 

    

 

 

    

 

 

 

Film

          

Production and IMAX DMR

     28,642       19,245        83,496        78,050  

Film distribution and post-production

     3,222       5,226        16,962        22,126  
  

 

 

   

 

 

    

 

 

    

 

 

 
     31,864       24,471        100,458        100,176  
  

 

 

   

 

 

    

 

 

    

 

 

 

Total

   $ 105,051     $ 77,415      $ 287,937      $ 282,755  
  

 

 

   

 

 

    

 

 

    

 

 

 

Gross margins

          

IMAX Theater Systems

          

IMAX systems(1)

          

Sales and sales-type leases

   $ 19,262     $ 11,715      $ 35,652      $ 36,974  

Ongoing rent, fees, and finance income

     3,630       4,055        13,388        13,271  

Other

     (273     398        102        1,057  
  

 

 

   

 

 

    

 

 

    

 

 

 
     22,619       16,168        49,142        51,302  
  

 

 

   

 

 

    

 

 

    

 

 

 

Theater system maintenance

     2,664       2,848        12,096        10,970  
  

 

 

   

 

 

    

 

 

    

 

 

 

Joint revenue sharing arrangements(1)

     17,769       8,968        44,565        37,308  
  

 

 

   

 

 

    

 

 

    

 

 

 

Film

          

Production and IMAX DMR(1)

     23,344       13,641        56,088        49,355  

Film distribution and post-production

     930       804        2,712        4,310  
  

 

 

   

 

 

    

 

 

    

 

 

 
     24,274       14,445        58,800        53,665  
  

 

 

   

 

 

    

 

 

    

 

 

 

Total

   $ 67,326     $ 42,429      $ 164,603      $ 153,245  
  

 

 

   

 

 

    

 

 

    

 

 

 

 

(1) IMAX systems include marketing and commission costs of $1.5 million and $2.5 million for the three and twelve months ended December 31, 2013, respectively (2012 — $0.6 million and $2.7 million, respectively). Joint revenue sharing arrangements segment margins include advertising, marketing and commission costs of $1.6 million and $3.6 million for the three and twelve months ended December 31, 2013, respectively (2012 — $1.3 million and $3.4 million, respectively). Production and DMR segment margins include marketing costs of $1.1 million and $4.2 million for the three and twelve months ended December 31, 2013, respectively (2012 — $1.1 million and $3.3 million, respectively). Distribution segment margins include marketing costs of $0.2 million and $0.4 million for the three and twelve months ended December 31, 2013, respectively (2012 — $0.3 million and $1.5 million, respectively).
* Includes a reclass of the Company’s owned and operated Nyack theater from continuing operations to discontinued operations.

 

9


IMAX CORPORATION

OTHER INFORMATION

(In thousands of U.S. dollars)

Non-GAAP Financial Measures:

In this release, the Company presents adjusted EBITDA, adjusted net income and adjusted net income per diluted share as supplemental measures of performance of the Company, which are not recognized under United States generally accepted accounting principles (“GAAP”). The Company presents adjusted EBITDA, adjusted net income and adjusted net income per diluted share because it believes that they are important supplemental measures of its comparable controllable operating performance and it wants to ensure that its investors fully understand the impact of its stock-based compensation (net of any related tax impact) on its net income. Management uses these measures to review operating performance on a comparable basis from period to period. However, these non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Adjusted EBITDA, adjusted net income and adjusted net income per diluted share should be considered in addition to, and not as a substitute for, net income and other measures of financial performance reported in accordance with GAAP.

Adjusted EBITDA is calculated on a basis consistent with the Company’s Credit Facility, which refers to Adjusted EBITDA as EBITDA. The Credit Facility provides that the Company will be required to maintain a Fixed Charge Coverage Ratio (as defined in the Credit Agreement) of not less than 1.1:1. The Company will also be required to maintain minimum EBITDA (as defined in the Credit Agreement) of $80.0 million on December 31, 2013, which increases to $90.0 million on December 31, 2014, and $100.0 million on December 31, 2015. The Company must also maintain a Maximum Total Leverage Ratio (as defined in the Credit Agreement) of 2.25:1 on December 31, 2013, which requirement decreases to 2.0:1 on December 31, 2014, and 1.75:1 on December 31, 2015. The ratio of total debt to EBITDA was nil:1 as at December 31, 2013, where Total Debt (as defined in the Credit Agreement) is the sum of all obligations evidenced by notes, bonds, debentures or similar instruments and was $nil. EBITDA is calculated as follows:

 

     For the      For the  
     3 months ended      12 months ended  
     December 31, 2013      December 31, 2013  
(In thousands of U.S. Dollars)              

Net income

   $ 27,829      $ 44,115  

Add:

     

Loss from equity-accounted investments

     1,759        2,757  

Provision for income taxes(1)

     9,906        16,470  

Interest expense, net of interest income

     321        1,290  

Depreciation and amortization, including film asset amortization

     8,011        36,685  

Write-downs, net of recoveries and receivable provisions

     1,057        1,336  

Stock and other non-cash compensation

     3,337        12,685  

Gain on curtailment of postretirement benefits

     —          (2,185
  

 

 

    

 

 

 

Adjusted EBITDA

   $ 52,220      $ 113,153  
  

 

 

    

 

 

 

 

(1) Includes a tax recovery in discontinued operations of less than $0.1 million and $0.2 million for the three and twelve months ended December 31, 2013, respectively.

 

10


IMAX CORPORATION

OTHER INFORMATION

(in thousands of U.S. dollars)

 

Adjusted Net Income and Adjusted Diluted Per Share Calculations – Quarter Ended December 31, 2013 vs. 2012:

The Company reported net income of $27.8 million or $0.41 per basic share and $0.40 per diluted share for the fourth quarter of 2013 as compared to $12.9 million or $0.20 per basic share and $0.19 per diluted share for the fourth quarter of 2012. Net income for the quarter includes a $3.2 million charge or $0.04 per diluted share (2012 – $2.9 million or $0.04 per diluted share) for stock-based compensation. Adjusted net income, which consists of net income excluding the impact of stock-based compensation and the related tax impact, was $30.8 million or $0.44 per diluted share in the fourth quarter of 2013 as compared to adjusted net income of $15.7 million or $0.23 per diluted share for the fourth quarter of 2012. A reconciliation of net income, the most directly comparable U.S. GAAP measure, to adjusted net income and adjusted net income per diluted share is presented in the table below:

 

     Three Months Ended
December 31, 2013
     Three Months Ended
December 31, 2012
 
     Net Income     Diluted EPS      Net Income     Diluted EPS  

Reported

   $ 27,829     $ 0.40      $ 12,883     $ 0.19  

Adjustments:

         

Stock-based compensation

     3,156       0.04        2,861       0.04  

Tax impact on item listed above

     (185     —          (74     —    
  

 

 

   

 

 

    

 

 

   

 

 

 

Adjusted

   $ 30,800     $ 0.44      $ 15,670     $ 0.23  
  

 

 

   

 

 

    

 

 

   

 

 

 

Weighted average diluted shares outstanding

       69,334          68,281  
    

 

 

      

 

 

 

Adjusted Net Income and Adjusted Diluted Per Share Calculations – Year Ended December 31, 2013 vs. 2012:

The Company reported net income of $44.1 million or $0.66 per basic share and $0.64 per diluted share for the year ended December 31, 2013 as compared to net income of $41.3 million or $0.63 per basic share and $0.61 per diluted share for the year ended December 31, 2012. Net income for the year ended December 31, 2013 includes an $11.9 million charge or $0.17 per diluted share (2012 — $13.1 million or $0.19 per diluted share) for stock-based compensation. Adjusted net income, which consists of net income excluding the impact of stock-based compensation and the related tax impact, was $55.7 million or $0.81 per diluted share for the year ended December 31, 2013 as compared to adjusted net income of $54.3 million or $0.80 per diluted share for the year ended December 31, 2012. A reconciliation of net income, the most directly comparable U.S. GAAP measure, to adjusted net income and adjusted net income per diluted share is presented in the table below:

 

     Year Ended
December 31, 2013
     Year Ended
December 31, 2012
 
     Net Income     Diluted EPS      Net Income     Diluted EPS  

Net income

   $ 44,115     $ 0.64      $ 41,337     $ 0.61  

Add:

         

Stock-based compensation

     11,928       0.17        13,113       0.19  

Tax impact on items listed above

     (344     —          (160     —    
  

 

 

   

 

 

    

 

 

   

 

 

 

Adjusted net income

   $ 55,699     $ 0.81      $ 54,290     $ 0.80  
  

 

 

   

 

 

    

 

 

   

 

 

 

Weighted average diluted shares outstanding

       68,961          67,933  
    

 

 

      

 

 

 

 

11


Free Cash Flow:

Free cash flow is defined as cash provided by operating activities minus cash used in investing activities (from the consolidated statements of cash flows). Cash provided by operating activities consist of net income, plus depreciation and amortization, plus the change in deferred income taxes, plus other non-cash items, plus changes in working capital, less investment in film assets, plus other changes in operating assets and liabilities. Cash used in investing activities includes capital expenditures, acquisitions and other cash used in investing activities. Management views free cash flow, a non-GAAP measure, as a measure of the Company’s after-tax cash flow available to reduce debt, add to cash balances, and fund other financing activities. A reconciliation of cash provided by operating activities to free cash flow is presented in the table below:

 

     For the
3 months ended
December 31, 2013
    For the
12 months ended
December 31, 2013
 
(In thousands of U.S. Dollars)             

Net cash provided by operating activities

   $ 22,058     $ 55,033  

Net cash (used in) investing activities

     (15,435     (42,277
  

 

 

   

 

 

 

Free cash flow

   $ 6,623     $ 12,756  
  

 

 

   

 

 

 

 

12